Navigation Links
Hazelden Names Leadership Team for New Recovery Center in Naples, Florida
Date:11/23/2009

CENTER CITY, Minn., Nov. 23 /PRNewswire/ -- Hazelden, the internationally renowned nonprofit addiction treatment center, today announced the leadership team for its new recovery center in Naples, Florida. Hazelden's 47-bed facility in Naples is scheduled to open in late March 2010, and will initially provide addiction treatment programs for adults, including a full array of family and outpatient services.

Michael Demask, Ph.D., will serve as executive director of Hazelden's facility in Naples, with Brenda Iliff, M.A., L.A.D.C., as clinical director, and Heather Burton, M.A., L.A.D.C., as outreach manager.

"We are pleased to announce this outstanding leadership team for our new Naples program," says Mark Mishek, Hazelden president and CEO. "With leadership in place, Hazelden is now only a few months away from being able to reach and help individuals and families in the Florida area find lasting freedom from addiction to alcohol and other drugs."

  • Demask currently serves as dean of the Hazelden Graduate School of Addiction Studies based in Center City, Minnesota. In addition, he has been a professor at the graduate school for nine years, teaching and supervising masters level students. Prior to joining Hazelden, Demask held clinical and leadership positions in a variety of addiction treatment centers in Florida, including programs in Aventura, Bartow, Miami Shores, Orlando, Bowling Green, and Tampa. He completed his doctoral work in Counseling Leadership and Administration at Barry University in Miami Shores, and his master's degree in Rehabilitation Counseling at the University of South Florida in Tampa.
  • Iliff currently serves as the clinical director of Hazelden's Women's Recovery Center in Center City, Minn. Prior to that role, she was executive director of Hazelden's Fellowship Club in St. Paul, Minn., and has held clinical and leadership roles with Hazelden since 1994. Iliff also serves as an adjunct as
    '/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hazelden and Dartmouth Psychiatric Research Center form publishing partnership
2. Hazelden to Open New Treatment Facility in Florida
3. William C. Moyers Appointed Vice President of Foundation Relations for Hazelden
4. National Expert on Prescription Drug Abuse, Addicted Physicians Available for Media Interviews From Hazelden
5. The Rev. Michael J. OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees
6. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
7. Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Dont Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey
8. Mark G. Mishek Is New President and CEO of Hazelden
9. Hazelden Publishing Unveils Valuable New Resource for Women Seeking Recovery From Addiction
10. Hazelden President and CEO Ellen Breyer to Step Down April 4
11. Hazelden Publishing Launches Parent Toolkit During National Bullying Prevention Awareness Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) ... owing to novel medical indications created and due to ... societies where physical appearance is extremely valued. Although the ... competitors, new companies and technologies are setting ground for ... put the price of 1st-gen products under pressure, only ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, ... invasive procedure known as morcellation carries a risk of spreading ... more clearly. Twenty-seven of every 10,000 women who had ... the procedure, researchers found, with the odds being highest for ... hysterectomy with morcellation use a power cutter to slice uterine ...
(Date:7/22/2014)... French . Montreal, ... step out for a cigarette twice as often as smokers ... who have the hardest time shaking off the habit may ... of. , Those insights were among the collective findings recently ... by a team of researchers based in part at Concordia ...
(Date:7/22/2014)... 22, 2014 5i Sciences, a medical ... appointment of Molly Coye, M.D., M.P.H. to a role ... renowned authority on the market introduction of innovative technologies ... she will advise on strategies for building a successful ... technology. Dr. Coye is currently the Chief Innovation ...
(Date:7/22/2014)... 2014 The Latin America Drilling fluid and ... and completion fluid market in Latin America with analysis and ... in Latin America is estimated to grow from around $0.93 ... CAGR of 9.2%, for the given period. , Browse through ... fluid Market Report, to get an idea of the in-depth ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6
... Announces 2008,Journalistic Achievement Awards, NEW YORK, May ... Show are among winners receiving top honors,in the ... for Aesthetic Plastic Surgery (ASAPS). Selected from among ... their awards on May,6th, at ASAPS, Annual Meeting ...
... $12.5 million private placement, SHANGHAI, China, May ... or "ATG") (OTC Bulletin Board: AAXT),today announced that, ... of all the outstanding common stock of Asian ... ("ABM"),pursuant to a share exchange agreement. ATG acquired ...
... Many women under age 55 arent seeking timely treatment for ... reaction to follow a Hollywood script tightening in the ... one knee. , Thats the finding of researchers who presented ... on Quality of Care and Outcomes Research (QCOR) in Cardiovascular ...
... Finding could help men with precancerous lesions avoid unnecessary ... Spanish researchers report they may have found a way ... develop into cancer. , The findings, published in the ... show a link between high-grade prostatic intraepithelial neoplasia (HG-PIN) ...
... Wound Closure System earns high marks from ... combat surgeons, ... U.S. Army combat support surgeons in Baghdad show that a new,medical device ... and limbs of soldiers and civilians., A team of battle zone ...
... the Decade Announced at Special 10th Anniversary ... Ceremony in Washington, DC -, ... honor six inspiring winners at the 10th annual Welcome Back Awards,ceremony ... the,Welcome Back Awards has recognized individuals for their outstanding,commitments to mental ...
Cached Medicine News:Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 2Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 2Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 4Health News:Some women more likely to miss or ignore heart attack warning signs 2Health News:Some women more likely to miss or ignore heart attack warning signs 3Health News:Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer 2Health News:New Surgical Device Saves Lives and Limbs on Iraq's Front Lines 2Health News:New Surgical Device Saves Lives and Limbs on Iraq's Front Lines 3Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 2Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 3Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 4Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 5Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 6
(Date:7/22/2014)... , July 22, 2014  Neurotrope Bioscience, Inc., ... a world-wide, exclusive license agreement with the Icahn School ... ( Mount Sinai ) to utilize its ... Bryostatin-1 in the treatment of Niemann-Pick Type C Disease ... afflicted with Alzheimer-like symptoms. The license also covers other ...
(Date:7/22/2014)...  According to the American Optometric Association (AOA), parents ... devices. An AOA survey reports that 83 percent of ... they use an electronic device for three or more ... parents revealed that only 40 percent of parents believe ... amount of time. Eye doctors are concerned that this ...
(Date:7/22/2014)... MARCOS, Texas , July 22, 2014 Quantum Materials ... and Mr. John Heaton to the Board of ... by Dr. Ghassan Jabbour , QMC Chief Science Officer and ... Michael Wong of Rice University and Mr. Tomio ... Japan . " Quantum Materials welcomes ...
Breaking Medicine Technology:Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... Pharmaceuticals, Inc. announced today that the U.S. Food ... drug status for the treatment of pancreatic cancer. ... the marketed chemotherapy drug irinotecan.  MM-398 is partnered ... Taiwan under the designation PEP02. (Logo: ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced ... the NASDAQ Global Select Market closes on Tuesday, August 9, ... Executive Officer, will host a conference call and webcast at ... the financial results for the second quarter 2011 and to ...
Cached Medicine Technology:FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9 3
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... kit measures the biologically active form ... is a valuable prognostic marker for cardiovascular ... plasma vitamin B6 level and Coronary Heart ... reactions of homocysteine to cystathionine and then ...
... volume for use with 4, 8, or 12 ... withdrawal of nearly all of the solution. Corners ... Made of natural virgin polystyrene containing no regrinds. ... by irradiation. Dimensions: 78 mm W x 152 ...
Volume: 10 ml; Volume Graduation: 1/10 ml...
Medicine Products: